In particular, it seems that OPG in-vitro protects vascular calcification whereas in-vivo higher OPG plasma levels are significantly associated with endothelial dysfunction and the development of coronary heart disease [36, 39–40]. The gene discussed is TNFRSF11B; the disease is endothelial dysfunction.